The University of Southampton
University of Southampton Institutional Repository

A multicentre observational study evaluating image-guided radiotherapy for more accurate partial-breast intensity-modulated radiotherapy: comparison with standard imaging technique

A multicentre observational study evaluating image-guided radiotherapy for more accurate partial-breast intensity-modulated radiotherapy: comparison with standard imaging technique
A multicentre observational study evaluating image-guided radiotherapy for more accurate partial-breast intensity-modulated radiotherapy: comparison with standard imaging technique
Background

Whole-breast radiotherapy (WBRT) is the standard treatment for breast cancer following breast-conserving surgery. Evidence shows that tumour recurrences occur near the original cancer: the tumour bed. New treatment developments include increasing dose to the tumour bed during WBRT (synchronous integrated boost) and irradiating only the region around the tumour bed, for patients at high and low risk of tumour recurrence, respectively. Currently, standard imaging uses bony anatomy to ensure accurate delivery of WBRT. It is debatable whether or not more targeted treatments such as synchronous integrated boost and partial-breast radiotherapy require image-guided radiotherapy (IGRT) focusing on implanted tumour bed clips (clip-based IGRT).

Objectives

Primary – to compare accuracy of patient set-up using standard imaging compared with clip-based IGRT. Secondary – comparison of imaging techniques using (1) tumour bed radiotherapy safety margins, (2) volume of breast tissue irradiated around tumour bed, (3) estimated breast toxicity following development of a normal tissue control probability model and (4) time taken.

Design

Multicentre observational study embedded within a national randomised trial: IMPORT-HIGH (Intensity Modulated and Partial Organ Radiotherapy – HIGHer-risk patient group) testing synchronous integrated boost and using clip-based IGRT.

Setting

Five radiotherapy departments, participating in IMPORT-HIGH.

Participants

Two-hundred and eighteen patients receiving breast radiotherapy within IMPORT-HIGH.

Interventions

There was no direct intervention in patients’ treatment. Experimental and control intervention were clip-based IGRT and standard imaging, respectively. IMPORT-HIGH patients received clip-based IGRT as routine; standard imaging data were obtained from clip-based IGRT images.

Main outcome measures

Difference in (1) set-up errors, (2) safety margins, (3) volume of breast tissue irradiated, (4) breast toxicity and (5) time, between clip-based IGRT and standard imaging.

Results

The primary outcome of overall mean difference in clip-based IGRT and standard imaging using daily set-up errors was 2–2.6?mm (p?<?0.001). Heterogeneity testing between centres found a statistically significant difference in set-up errors at one centre. For four centres (179 patients), clip-based IGRT gave a mean decrease in the systematic set-up error of between 1?mm and 2?mm compared with standard imaging. Secondary outcomes were as follows: clip-based IGRT and standard imaging safety margins were less than 5?mm and 8?mm, respectively. Using clip-based IGRT, the median volume of tissue receiving 95% of prescribed boost dose decreased by 29?cm3 (range 11–193?cm3) compared with standard imaging. Difference in median time required to perform clip-based IGRT compared with standard imaging was X-ray imaging technique dependent (range 8–76 seconds). It was not possible to estimate differences in breast toxicity, the normal tissue control probability model indicated that for breast fibrosis maximum radiotherapy dose is more important than volume of tissue irradiated.

Conclusions and implications for clinical practice

Margins of less than 8?mm cannot be used safely without clip-based IGRT for patients receiving concomitant tumour bed boost, as there is a risk of geographical miss of the tumour bed being treated. In principle, smaller but accurately placed margins may influence local control and toxicity rates, but this needs to be evaluated from mature clinical trial data in the future.

Funding

This project was funded by the Efficacy and Mechanism Evaluation (EME) programme, a MRC and NIHR partnership.
2050-4365
Harris, E.
148b60b4-c394-47bb-b59f-9fea7c934628
Mukesh, M.
5da1d728-8d1e-42d8-9969-f75213ebb175
Jena, R.
2e242a69-4a8a-4f20-b0ba-7242d6b4f1fc
Baker, A.
cfec9010-f617-4df0-b34f-683940b7bf2c
Bartelink, H.
45ffdaa1-1847-4dd5-9fee-209ed440f128
Brooks, C.
91d99e42-37f5-4b2b-87a2-c3df0c926b5f
Dean, J.
1e0dc1e6-58ff-4fcb-b37e-049caeda497c
Donovan, E.
f10e198f-0476-4a3f-87a8-46335881db20
Collette, S.
00542331-33d1-462a-92fd-c7c623556bd9
Eagle, S.
5db85e35-d842-45d0-b024-0989745afd7c
Fenwick, J.D.
14e0a72d-00b0-4e37-b982-fa0dd3289b1d
Graham, P.H.
69a82f0e-7976-4868-bc7d-1cd6a1a1b926
Haviland, Joanne S.
569aa43b-15bd-4e9d-b4a5-e68a84334cfe
Kirby, A.M.
553f52fa-b7a1-4d97-8b0b-dffbd35a6b33
Mayles, H.
8f37034f-a0ba-46b5-bf3f-0e199404dbaf
Mitchell, R.A.
62356f5b-5cc8-4679-96be-b14a5b4579a9
Perry, R.
40cdf881-b9da-4bac-a76a-89c6fcf156a5
Poortmans, P.
5debdc90-c093-4f7c-bd36-0ae6d401cbbf
Poynter, A.
9af01e89-3f1a-48f2-8ae9-d1f99cb8761d
Shentall, G.
b4e35c2a-cf77-40a8-8fb7-22877300991e
Titley, J.
20bcb486-5ab2-41ce-bfb3-844674a29062
Thompson, A.
93b513c2-90fc-4d2e-b8d8-8737edd0bc09
YarnolD, J.R.
0e51cc2f-3eb1-464f-bf61-d2ac2e86e958
Coles, C.E.
627dfe0d-3876-4fcf-8e70-431e3649e257
Evans, P.M.
59193ce5-2b34-4e1f-b586-21451818051f
Harris, E.
148b60b4-c394-47bb-b59f-9fea7c934628
Mukesh, M.
5da1d728-8d1e-42d8-9969-f75213ebb175
Jena, R.
2e242a69-4a8a-4f20-b0ba-7242d6b4f1fc
Baker, A.
cfec9010-f617-4df0-b34f-683940b7bf2c
Bartelink, H.
45ffdaa1-1847-4dd5-9fee-209ed440f128
Brooks, C.
91d99e42-37f5-4b2b-87a2-c3df0c926b5f
Dean, J.
1e0dc1e6-58ff-4fcb-b37e-049caeda497c
Donovan, E.
f10e198f-0476-4a3f-87a8-46335881db20
Collette, S.
00542331-33d1-462a-92fd-c7c623556bd9
Eagle, S.
5db85e35-d842-45d0-b024-0989745afd7c
Fenwick, J.D.
14e0a72d-00b0-4e37-b982-fa0dd3289b1d
Graham, P.H.
69a82f0e-7976-4868-bc7d-1cd6a1a1b926
Haviland, Joanne S.
569aa43b-15bd-4e9d-b4a5-e68a84334cfe
Kirby, A.M.
553f52fa-b7a1-4d97-8b0b-dffbd35a6b33
Mayles, H.
8f37034f-a0ba-46b5-bf3f-0e199404dbaf
Mitchell, R.A.
62356f5b-5cc8-4679-96be-b14a5b4579a9
Perry, R.
40cdf881-b9da-4bac-a76a-89c6fcf156a5
Poortmans, P.
5debdc90-c093-4f7c-bd36-0ae6d401cbbf
Poynter, A.
9af01e89-3f1a-48f2-8ae9-d1f99cb8761d
Shentall, G.
b4e35c2a-cf77-40a8-8fb7-22877300991e
Titley, J.
20bcb486-5ab2-41ce-bfb3-844674a29062
Thompson, A.
93b513c2-90fc-4d2e-b8d8-8737edd0bc09
YarnolD, J.R.
0e51cc2f-3eb1-464f-bf61-d2ac2e86e958
Coles, C.E.
627dfe0d-3876-4fcf-8e70-431e3649e257
Evans, P.M.
59193ce5-2b34-4e1f-b586-21451818051f

Harris, E., Mukesh, M. and Jena, R. et al. (2014) A multicentre observational study evaluating image-guided radiotherapy for more accurate partial-breast intensity-modulated radiotherapy: comparison with standard imaging technique. Efficacy and Mechanism Evaluation, 1 (3). (PMID:25642565)

Record type: Article

Abstract

Background

Whole-breast radiotherapy (WBRT) is the standard treatment for breast cancer following breast-conserving surgery. Evidence shows that tumour recurrences occur near the original cancer: the tumour bed. New treatment developments include increasing dose to the tumour bed during WBRT (synchronous integrated boost) and irradiating only the region around the tumour bed, for patients at high and low risk of tumour recurrence, respectively. Currently, standard imaging uses bony anatomy to ensure accurate delivery of WBRT. It is debatable whether or not more targeted treatments such as synchronous integrated boost and partial-breast radiotherapy require image-guided radiotherapy (IGRT) focusing on implanted tumour bed clips (clip-based IGRT).

Objectives

Primary – to compare accuracy of patient set-up using standard imaging compared with clip-based IGRT. Secondary – comparison of imaging techniques using (1) tumour bed radiotherapy safety margins, (2) volume of breast tissue irradiated around tumour bed, (3) estimated breast toxicity following development of a normal tissue control probability model and (4) time taken.

Design

Multicentre observational study embedded within a national randomised trial: IMPORT-HIGH (Intensity Modulated and Partial Organ Radiotherapy – HIGHer-risk patient group) testing synchronous integrated boost and using clip-based IGRT.

Setting

Five radiotherapy departments, participating in IMPORT-HIGH.

Participants

Two-hundred and eighteen patients receiving breast radiotherapy within IMPORT-HIGH.

Interventions

There was no direct intervention in patients’ treatment. Experimental and control intervention were clip-based IGRT and standard imaging, respectively. IMPORT-HIGH patients received clip-based IGRT as routine; standard imaging data were obtained from clip-based IGRT images.

Main outcome measures

Difference in (1) set-up errors, (2) safety margins, (3) volume of breast tissue irradiated, (4) breast toxicity and (5) time, between clip-based IGRT and standard imaging.

Results

The primary outcome of overall mean difference in clip-based IGRT and standard imaging using daily set-up errors was 2–2.6?mm (p?<?0.001). Heterogeneity testing between centres found a statistically significant difference in set-up errors at one centre. For four centres (179 patients), clip-based IGRT gave a mean decrease in the systematic set-up error of between 1?mm and 2?mm compared with standard imaging. Secondary outcomes were as follows: clip-based IGRT and standard imaging safety margins were less than 5?mm and 8?mm, respectively. Using clip-based IGRT, the median volume of tissue receiving 95% of prescribed boost dose decreased by 29?cm3 (range 11–193?cm3) compared with standard imaging. Difference in median time required to perform clip-based IGRT compared with standard imaging was X-ray imaging technique dependent (range 8–76 seconds). It was not possible to estimate differences in breast toxicity, the normal tissue control probability model indicated that for breast fibrosis maximum radiotherapy dose is more important than volume of tissue irradiated.

Conclusions and implications for clinical practice

Margins of less than 8?mm cannot be used safely without clip-based IGRT for patients receiving concomitant tumour bed boost, as there is a risk of geographical miss of the tumour bed being treated. In principle, smaller but accurately placed margins may influence local control and toxicity rates, but this needs to be evaluated from mature clinical trial data in the future.

Funding

This project was funded by the Efficacy and Mechanism Evaluation (EME) programme, a MRC and NIHR partnership.

This record has no associated files available for download.

More information

Published date: November 2014
Organisations: Faculty of Health Sciences

Identifiers

Local EPrints ID: 378547
URI: http://eprints.soton.ac.uk/id/eprint/378547
ISSN: 2050-4365
PURE UUID: 05bc4420-abcc-4e7d-b853-77ad1de6ebe1

Catalogue record

Date deposited: 08 Jul 2015 12:05
Last modified: 22 Jul 2022 19:27

Export record

Contributors

Author: E. Harris
Author: M. Mukesh
Author: R. Jena
Author: A. Baker
Author: H. Bartelink
Author: C. Brooks
Author: J. Dean
Author: E. Donovan
Author: S. Collette
Author: S. Eagle
Author: J.D. Fenwick
Author: P.H. Graham
Author: Joanne S. Haviland
Author: A.M. Kirby
Author: H. Mayles
Author: R.A. Mitchell
Author: R. Perry
Author: P. Poortmans
Author: A. Poynter
Author: G. Shentall
Author: J. Titley
Author: A. Thompson
Author: J.R. YarnolD
Author: C.E. Coles
Author: P.M. Evans

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×